Braveheart Investment Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Braveheart Investment Group heeft een totaal eigen vermogen van £3.5M en een totale schuld van £0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk £3.5M en £43.6K.

Belangrijke informatie

Verhouding schuld/eigen vermogen

UK£0

Schuld

Rente dekkingsratio	n/a
Contant	UK£1.09m
Aandelen	UK£3.46m
Totaal verplichtingen	UK£43.60k
Totaal activa	UK£3.50m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( £1.2M ) BRH } overtreffen de korte termijn passiva ( £43.6K ).

Langlopende schulden: BRH heeft geen langlopende schulden.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: BRH is schuldenvrij.

Schuld verminderen: BRH had 5 jaar geleden geen schulden.

Schuldendekking: BRH heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: BRH heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

Braveheart Investment Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

First half 2025 earnings released: EPS: UK£0.001 (vs UK£0.011 loss in 1H 2024)

Braveheart Investment Group plc (AIM:BRH) acquired 29.51% stake in IQ-AI Limited (LSE:IQAI) from Trevor Brown and Free Association Books Limited for £0.719 million.

Braveheart Investment Group plc (AIM:BRH) acquired an additional 15% stake in Gyrometric Systems Limited for £0.0225 million.

Insufficient new directors

Full year 2024 earnings released: UK£0.11 loss per share (vs UK£0.027 profit in FY 2023)

Braveheart Investment Group plc, Annual General Meeting, Jul 18, 2024

Bruker Uk Limited completed the acquisition of Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders.

Bruker Uk Limited entered into a conditional sale and purchase agreement to acquire Phasefocus Holdings Limited from Braveheart Investment Group plc (AIM:BRH) and other shareholders for £5 million.

First half 2024 earnings released: UK£0.011 loss per share (vs UK£0.01 loss in 1H 2023)

New minor risk - Share price stability

New major risk - Market cap size

Braveheart Investment Group plc, Annual General Meeting, Jul 28, 2023

Full year 2023 earnings released: EPS: UK£0.027 (vs UK£0.031 in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.049 profit in 1H 2022)

Braveheart Investment Group plc (AIM:BRH) acquired additional 4.7% stake in Autins Group plc (AIM:AUTG) for £0.16 million.

Braveheart Investment Group plc (AIM:BRH) acquired additional 8.31% minority stake in Aukett Swanke Group Plc (AIM:AUK) from Andrew Murdoch for £0.33 million.

Braveheart Investment Group plc (AIM:BRH) agreed to acquire a 7.89% stake in Aukett Swanke Group Plc (AIM : AUK) from Trevor Brown for £0.22 million.

Braveheart Investment Group plc Provides the Update on Paraytec

Full year 2022 earnings released: EPS: UK£0.031 (vs UK£0.37 in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: EPS UK£0.049 (vs UK£0.013 in 1H 2021)

Braveheart Investment Group plc Announces Further Update re Paraytec AD Scanner Project

CEO & Director recently sold UK£556k worth of stock

Full year 2021 earnings released

Braveheart Investment Group plc Updates on the Paraytec AD Scanner Project

David Orton, Paul Orton and Janet Poliakoff agreed to acquire a 56.07% stake in Gyrometric Systems Limited from Braveheart Investment Group plc (AIM:BRH) and Remote Monitored Systems plc (AIM:RMS).

CEO & Director recently sold UK£827k worth of stock

Independent Non-Executive Director has left the company

CEO & Director recently sold UK£1.7m worth of stock

CEO & Director recently sold UK£689k worth of stock

New 90-day high: UK£0.80

Braveheart Investment Group plc Provides Update Concerning Progress to Develop Covid-19 Test That Paraytec Limited Is Working on in Conjunction with the University of Sheffield

CEO & Director recently sold UK£214k worth of stock

First half 2021 earnings released: EPS UK£0.013

New 90-day high: UK£0.47

New 90-day high: UK£0.37

Remote Monitored Systems plc (AIM:RMS) agree to acquire 51.72% stake in Pharm 2 Farm Limited from Braveheart Investment Group plc (AIM:BRH) for £1.2 million.

Braveheart Investment Group plc Update on the Pharm2farm Anti-Viral Mask Project

New 90-day high - UK£0.21

New 90-day high - UK£0.21

New 90-day high - UK£0.20

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven